/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Kiniksa

Kiniksa

Lexington, USA

Kiniksa Pharmaceuticals develops and evaluates medicines, including an investigational monoclonal antibody for recurrent pericarditis

Healthcare & Biotech

Kiniksa, based in Lexington, USA, has 2 investors on file, among them Boxer Capital and Sofinnova. Its site was last checked 13 Nov 2026: site answers.

kiniksa.com

Investors

2 investors on file
InvestorEvidenceType
Boxer CapitalPortfolio pageVenture capital
SofinnovaPortfolio pageVenture capital

In the news

2 headlines naming Kiniksa
Kiniksa Pharmaceuticals International, plc $KNSA Shares Acquired by Lisanti Capital Growth LLCthemarketsdaily.comExitKiniksa Pharmaceuticals International (NASDAQ:KNSA) CEO Sanj Patel Sells 151,300 Shares of Stockthemarketsdaily.com

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from Boxer Capital

40 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (5%), Fintech (3%).

Aligos TherapeuticsAligos Therapeutics develops therapies for liver and viral diseasesAvidity BiosciencesAvidity Biosciences is developing RNA therapeutics for rare muscle dis…BioAtlaBioAtla develops novel therapeutics with improved therapeutic index th…Boundless BioBoundless Bio develops therapies for patients with intractable oncogen…Cabaletta BioCabaletta Bio develops T cell therapies to treat autoimmune diseases

See Boxer Capital's full profile · Who invests alongside it

More from Sofinnova

42 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (97%), Fintech (3%).

Aeovian PharmaceuticalsAeovian Pharmaceuticals develops small molecules to treat certain rare…Alimera SciencesAscendis Pharma A/SAscendis Pharma is a biopharmaceutical company that develops new thera…Axonis TherapeuticsAxonis Therapeutics develops medicines targeting neurological disorder…BioAge LabsThe company is harnessing the biology of human aging to develop new th…

See Sofinnova's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Kiniksa and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Boxer Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/kiniksa.com/investors

# also
GET /v1/companies/kiniksa.com
GET /v1/companies/kiniksa.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing